Anemia and iron deficiency in the elderly. Prevalence, diagnostics and new therapeutic options;Anämie und Eisenmangel in der Geriatrie. Prävalenz, Diagnostik und neue Therapieoptionen

Zeitschrift fur Gerontologie und Geriatrie

Volumn 45, Issue 3, 2012, Pages 191-196

  Rohrig G ^a,b   Doehner, W ^c   Schaefer, R M ^d   Schulz, R J ^a,b  

^a St Marien Hospital Köln   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Anemia, iron deficiency; Erythropoietin; Geriatrics; Heart failure; Kidney diseases

Indexed keywords

ARTICLE; GERIATRICS; GERMANY; HUMAN; IRON DEFICIENCY ANEMIA; PRACTICE GUIDELINE; STANDARD;

ANEMIA, IRON-DEFICIENCY; GERIATRICS; GERMANY; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 84859628431     PISSN: 09486704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00391-012-0320-8     Document Type: Article

References (43)

1. Agarwal N et al (2009) Anemia of chronic diseases (anemia of inflammation). Acta Haematol 122: 103-108.
2. Anker SD et al (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361: 2436-2447.
3. Beard et al (1997) Risk of Alzheimer's disease among elderly people with anemia: population based investigations in Olmsted County, Minnesota. Ann Epidemiol 7: 219-224.
4. Beghé C et al (2004) Prevalence and outcomes of anemia in geriatrics: a systematic review of the literature. Am J Med 116: 3S-10S.
5. Beutler E, Waalen J (2006) The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood 107(5): 1747-1750.
6. Blanc B, Finch CA, Hallberg L et al (1968) Nutritional anaemias. Report of a WHO Scientific Group. WHO Tech Rep Ser 405: 1-40.
7. Bolger AP, Bartlett FR, Penston HS et al (2006) Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. J Am Coll Cardiol 48: 1225-1227.
8. Clase CM et al (2007) Relationship between glomerular filtration rate and the prevalence of metabolic abnormalities: results from the third National Health and Nutrition Examination Survey (NHANES III). Nephron Clin Pract 105(4): c178-84.
9. Domenico I de et al (2009) Hepcidin induced internalization of ferroportin requires binding and cooperative interaction with JAK-2. Proc Natl Acad Sci USA 106: 3800-3805.
10. Du X et al (2008) The serine protease TMPRSS6 is required to sense iron deficiency. Science 320: 1088-1092.
11. Ezekowitz JA, McAlister FA, Armstrong PW (2003) Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12, 065 patients with new-onset heart failure. Circulation 107(2): 223-225.
12. Fishbane S (2007) Iron management in non-dialysis dependent CKD. Am J Kidney Dis 49(6): 736-743.
13. Fishbane S et al (2009) Iron deficiency in non-dialysis chronic kidney disease. Kidney Int 75: 752-754.
14. Gaskell H et al (2008) Prevalence of anaemia in older persons: systematic review. BMC Geriatr 8: 1.
15. Gotloib L et al (2006) Iron deficiency is a common cause of of anemia in chronic kidney disease and can often be corrected with intravenous iron. J Nephrol 19: 161-167.
16. Guralnik JM, Eisenstaedt RS, Ferrucci L et al (2004) Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 104(8): 2263-2268.
17. Hsu CY et al (2002) Iron status and hemoglobin level in chronic renal insufficiency. J Am Soc Nephrol 13: 2783-2786.
18. Jacober ML et al (2007) Anaemia in patients with cancer: role of inflammatory activity on iron metabolism and severity of anaemia. Med Oncol 24(3): 323-329.
19. Kikuchi M et al (2001) Five-year survival of older people with anemia: variation with haemoglobin concentration. J Am Geriatr Soc 49: 1226-1228.
20. Kosiborod M, Smith GL, Radford MJ et al (2003) The prognostic importance of anemia in patients with heart failure. Am J Med 114: 112-119.
21. Krum H, Jelinek MV, Stewart S et al (2011) 2011 update to National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand Guidelines for the prevention, detection and management of chronic heart failure in Australia, 2006. Med J Aust 194: 405-409.
22. Lee P et al (2008) The anemia of ageing is not associated with increased plasma hepcidin levels. Blood Cells Mol Dis 41: 252-254.
23. Link H, Bokemeyer C (2008) S-3 Leitlinie "Anämie bei Krebs" der Deutschen Krebsgesellschaft, Arbeitskreis Supportive Maßnahmen in der Onkologie (ASO). Zuckschwerdt, München.
24. MacDougall IC (2001) Hyporesponsiveness to anemia therapy - what are we doing wrong? Perit Dial Int 21(Suppl 3): 225-230.
25. National Kidney Foundation: KDOQI (2006) Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 47(Suppl 3): 11-145.
26. Nemeth E et al (2004) Hepcidin regulates cellular iron reflux by binding to ferroportin and inducing its internalization. Science 306: 2090-2093.
27. Nemeth E et al (2003) Hepcidine a putative mediator of anemia of inflammation, is a type II acute phase protein. Blood 101: 2461-2463.
28. Nemeth E (2008) Iron regulation and erythropoiesis. Curr Opin Hematol 15: 169-175.
29. Nicolas G et al (2002) Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis 29(3): 327-335.
30. Okonko DO, Grzeslo A, Witkowski T et al (2008) Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency. FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol 51: 103-112.
31. Salive et al (1992) Anemia and hemoglobin levels in older persons: relationship with age, gender and health status. J Am Geriatr Soc 40: 489-496.
32. Schaefer RM et al (2009) Konsensuspapier - Eisen-Management bei Patienten mit chronischer Niereninsuffizienz. Nephro-News 6. http://www. medicom. cc.
33. Sharma R, Francis DP, Pitt B et al (2004) Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial. Eur Heart J 25(12): 1021-8.
34. Silverberg D, Wexler D, Blum M et al (2003) The cardio-renal anaemia syndrome: does it exist? Nephrol Dial Transplant 18(Suppl 8): viii7-12.
35. Silverberg DS, Wexler D, Blum M et al (2000) The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 35(7): 1737-1744.
36. Suzuki H et al (2009) Serum hepcidin-20 is elevated during the acute phase of myocardial infarction. Tohoku J Exp med 218(2): 93-98.
37. Tanner H, Moschovitis G, Kuster GM et al (2002) The prevalence of anemia in chronic heart failure. Int J Cardiol 86(1): 115-121.
38. Tessitore N et al (2010) Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents. Nephrol Dial Transplant (Epub ahead of print).
39. Thomas MC et al (2004) The burden of anaemia in type 2 diabetes and the role of nephropathy: a cross-sectional audit. Nephrol Dial Transplant 19(7): 1792-1797.
40. Truks J et al (2009) Two BMP responsive elements, STAT, and bZIP/HNF2/COUP motifs of the hepcidin promoter are critical for BMP, SMAD1, and HJV responsiveness. Blood 113: 688-695.
41. Ukarma L et al (2009) Hepcidin as a predictor of response to epoetin therapy in anemic cancer patients. Clin Chem 55(7): 1354-1360.
42. Weiss G et al (2009) Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy. Eur J Clin Invest 39(10): 883-890.
43. Zaritsky J et al (2009) Hepcidin - a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Neprol 6: 1015-1016.